ArticleNature reviews. Clinical oncology2014
Genetics: CALR mutations and a new diagnostic algorithm for MPN.
Article in Nature reviews. Clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.Leukemia · 2018Guideline
- Myeloproliferative neoplasms complicated with β-thalassemia: Two case report.World journal of clinical cases · 2022Article
- Retrospective analysis of the clinical features of 172 patients withMolecular cytogenetics · 2020Article
- The Role of New Technologies in Myeloproliferative Neoplasms.Frontiers in oncology · 2019Review
- Homozygous CALR Mutation in Primary Myelofibrosis and Its Effect on Disease Phenotype: A Case Report and Review of the Literature.Case reports in hematology · 2019Article
- A rare CALR variant mutation and a review of CALR in essential thrombocythemia.Journal of thrombosis and thrombolysis · 2018Review
- Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.Journal of clinical laboratory analysis · 2016Article
- Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.Leukemia & lymphoma · 2016Review
- Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016Article
- Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation.Bone marrow transplantation · 2016Article
- Recent advances in understanding myelofibrosis and essential thrombocythemia.F1000Research · 2016Review
- Constitutional genetic association with CALR mutations?Leukemia · 2015Article
- Clinical relevance between CALR mutation and myeloproliferative neoplasms.Stem cell investigation · 2015Review
- Calreticulin mutations in myeloproliferative neoplasms.Rambam Maimonides medical journal · 2014Article
- Article
- The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.Journal of hematology & oncology · 2014Article
- l-Amino acid oxidase isolated from Calloselasma rhodostoma snake venom induces cytotoxicity and apoptosis in JAK2V617F-positive cell lines.Revista brasileira de hematologia e hemoterapiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24514146What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.